CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer
BACKGROUND: Breast cancer is the leading cause of mortality from cancer in women worldwide, and cancer stem-like cell (CSC) is responsible for failure treatment of breast cancer. It plays an important role in resistant disease and metastasis. CD44/CD24 and ALDH are well-accepted protein markers of b...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134958/ https://www.ncbi.nlm.nih.gov/pubmed/30233217 http://dx.doi.org/10.2147/OTT.S174329 |